Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (REAL07)
Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of Treatment With Lenalidomide Plus R-CHOP21 (LR-CHOP21) for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (DLBCL)
Sponsor: Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
A PHASE2 clinical study on Follicular Lymphoma and Non Hodgkin Lymphoma, this trial is ongoing. The trial is conducted by Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte and has accumulated 7 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jun 2023 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Jan 2021 — Jun 2023 [monthly]
Unknown Status PHASE2
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
- Fondazione Italiana Linfomi - ETS
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alessandria, Italy , Aviano, Italy , Bari, Italy , Bologna, Italy , Brescia, Italy , Cagliari, Italy , Candiolo (TO), Italy , Genova, Italy , Milan, Italy , Napoli, Italy and 6 more locations